Search Results

JNJ-1661010 5 mg  | 99.80%

TargetMol

JNJ-1661010 (Takeda-25) is an effective and specific FAAH inhibitor (IC50: 10/ 12 nM for rat/human), shows >100-fold selectivity for FAAH-1 than FAAH-2.

More Information Supplier Page

JNJ-1661010 50 mg  | 99.80%

TargetMol

JNJ-1661010 (Takeda-25) is an effective and specific FAAH inhibitor (IC50: 10/ 12 nM for rat/human), shows >100-fold selectivity for FAAH-1 than FAAH-2.

More Information Supplier Page

JNJ-1661010 25 mg  | 99.80%

TargetMol

JNJ-1661010 (Takeda-25) is an effective and specific FAAH inhibitor (IC50: 10/ 12 nM for rat/human), shows >100-fold selectivity for FAAH-1 than FAAH-2.

More Information Supplier Page

JNJ-1661010 10 mg  | 99.80%

TargetMol

JNJ-1661010 (Takeda-25) is an effective and specific FAAH inhibitor (IC50: 10/ 12 nM for rat/human), shows >100-fold selectivity for FAAH-1 than FAAH-2.

More Information Supplier Page

Bimatoprost 10 mg  | Purity Not Available

TargetMol

Bimatoprost is a cloprostenol-derived amide that is used as an antihypertensive agent in the treatment of open-angle glaucoma and ocular hypertension.

More Information Supplier Page

Bimatoprost 25 mg  | Purity Not Available

TargetMol

Bimatoprost is a cloprostenol-derived amide that is used as an antihypertensive agent in the treatment of open-angle glaucoma and ocular hypertension.

More Information Supplier Page